Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 14
2003 8
2004 8
2005 5
2006 3
2007 14
2008 13
2009 6
2010 6
2011 7
2012 7
2013 2
2014 6
2015 9
2016 7
2017 4
2018 3
2019 9
2020 10
Text availability
Article attribute
Article type
Publication date

Search Results

127 results
Results by year
Filters applied: . Clear all
Page 1
Engineering Tumor Hypersusceptibility to Checkpoint Immunotherapy.
Fernández A. Fernández A. Trends Cancer. 2017 Oct;3(10):675-677. doi: 10.1016/j.trecan.2017.08.002. Epub 2017 Sep 4. Trends Cancer. 2017. PMID: 28958385 Review.
Postpartum use of oxytocin and volume of placental transfusion: a randomised controlled trial.
Vain NE, Satragno DS, Gordillo JE, Fernandez AL, Carrolli G, Romero NP, Prudent LM. Vain NE, et al. Among authors: fernandez al. Arch Dis Child Fetal Neonatal Ed. 2020 Jan;105(1):14-17. doi: 10.1136/archdischild-2018-316649. Epub 2019 May 9. Arch Dis Child Fetal Neonatal Ed. 2020. PMID: 31072967 Clinical Trial.
Targeted therapy to annihilate the immune-evading phenotype in cancer evolution.
Fernández A. Fernández A. Expert Opin Ther Targets. 2018 Jul;22(7):559-562. doi: 10.1080/14728222.2018.1450867. Epub 2018 Mar 13. Expert Opin Ther Targets. 2018. PMID: 29517390 No abstract available.
Drug-based cancer therapy to overcome immune resistance by steering tumor evolution.
Fernández A. Fernández A. Expert Opin Drug Discov. 2019 Jan;14(1):5-8. doi: 10.1080/17460441.2019.1550066. Epub 2018 Nov 29. Expert Opin Drug Discov. 2019. PMID: 30486683 No abstract available.
Reverse Engineering of a Thermosensing Regulator Switch.
Inda ME, Vazquez DB, Fernández A, Cybulski LE. Inda ME, et al. Among authors: fernandez a. J Mol Biol. 2019 Mar 1;431(5):1016-1024. doi: 10.1016/j.jmb.2019.01.025. Epub 2019 Jan 25. J Mol Biol. 2019. PMID: 30738600
Deep Learning to Therapeutically Target Unreported Complexes.
Fernández A. Fernández A. Trends Pharmacol Sci. 2019 Aug;40(8):551-554. doi: 10.1016/j.tips.2019.04.009. Epub 2019 May 21. Trends Pharmacol Sci. 2019. PMID: 31126630
Advanced Modeling Reconciles Counterintuitive Decisions in Lead Optimization.
Fernández A, Scott LR. Fernández A, et al. Trends Biotechnol. 2017 Jun;35(6):490-497. doi: 10.1016/j.tibtech.2016.12.003. Epub 2017 Jan 7. Trends Biotechnol. 2017. PMID: 28069262 Review.
Making Targeted Therapy Compatible with Checkpoint Immunotherapy.
Fernández A. Fernández A. Trends Biotechnol. 2017 Jul;35(7):582-584. doi: 10.1016/j.tibtech.2017.02.008. Epub 2017 Mar 8. Trends Biotechnol. 2017. PMID: 28283197
Editorial expression of concern: Non-adaptive origins of interactome complexity.
Fernández A, Lynch M. Fernández A, et al. Nature. 2014 Dec 18;516(7531):440. doi: 10.1038/nature13141. Epub 2014 Nov 26. Nature. 2014. PMID: 25470052 Free PMC article. No abstract available.
Driving the catalytic activity of a transmembrane thermosensor kinase.
Inda ME, Almada JC, Vazquez DB, Bortolotti A, Fernández A, Ruysschaert JM, Cybulski LE. Inda ME, et al. Among authors: fernandez a. Cell Mol Life Sci. 2020 Oct;77(19):3905-3912. doi: 10.1007/s00018-019-03400-1. Epub 2019 Dec 4. Cell Mol Life Sci. 2020. PMID: 31802141
127 results
Jump to page
Feedback